Transthoracic echocardiography assessment of early pulmonary revascularization for a sub-massive pulmonary embolism: A case report

[1]  A. Torbicki,et al.  Management of venous thrombo-embolism: an update. , 2014, European heart journal.

[2]  J. Kline,et al.  Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double‐blind, placebo‐controlled randomized trial , 2014, Journal of thrombosis and haemostasis : JTH.

[3]  Yu-hong Mi,et al.  Recombinant tissue plasminogen activator plus heparin compared with heparin alone for patients with acute submassive pulmonary embolism: one-year outcome , 2013, Journal of geriatric cardiology : JGC.

[4]  M. Olschewski,et al.  N-Terminal Pro-Brain Natriuretic Peptide or Troponin Testing Followed by Echocardiography for Risk Stratification of Acute Pulmonary Embolism , 2005, Circulation.

[5]  H. Putter,et al.  Right ventricular dysfunction and pulmonary obstruction index at helical CT: prediction of clinical outcome during 3-month follow-up in patients with acute pulmonary embolism. , 2005, Radiology.

[6]  H. Büller,et al.  Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism. , 2004, Archives of internal medicine.

[7]  M. Morris.  The Steering Committee , 2004, 2021 IEEE International Symposium on Performance Analysis of Systems and Software (ISPASS).

[8]  W. Haire.  Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. , 2003, Current hematology reports.

[9]  S. Goldhaber,et al.  Prognostic Role of Brain Natriuretic Peptide in Acute Pulmonary Embolism , 2003, Circulation.

[10]  olfgang,et al.  HEPARIN PLUS ALTEPLASE COMPARED WITH HEPARIN ALONE IN PATIENTS WITH SUBMASSIVE PULMONARY EMBOLISM , 2002 .

[11]  N. Punjabi,et al.  Treatment of right heart thromboemboli. , 2002, Chest.

[12]  F. Jardin,et al.  Acute cor pulmonale in massive pulmonary embolism: incidence, echocardiographic pattern, clinical implications and recovery rate , 2001, Intensive Care Medicine.

[13]  S. Goldhaber,et al.  Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial. , 1992, Journal of the American College of Cardiology.

[14]  Jeroen J. Bax,et al.  ESC Guidelines on the diagnosis and management of acute pulmonary embolism , 2014 .

[15]  M. Humbert,et al.  The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Endorsed by the European Respiratory Society (ERS) , 2014 .

[16]  Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: rationale and design of the Pulmonary Embolism Thrombolysis (PEITHO) trial. , 2012, American heart journal.

[17]  Piotr Pruszczyk,et al.  Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism , 2008 .